[ Inglés] The Latest MPN News: What the Experts Learned at ASH 2017

Published on

Topics include: Treatments and Understanding

What’s the latest information about MPN treatment and research? As part of our ASH 2017 coverage, Dr. John Crispino and Dr. Angela Fleischman, Joined Patient Power to share what they learned at this year’s annual meeting in Atlanta. Both researchers in the condition of myeloproliferative neoplasms (MPNs), they discussed treatment advances, particularly related to JAK inhibitors and interferon, the study of somatic mutations and how these learnings will aid in the development of future medicines. Tune in now to learn more from these MPN experts.

This is an MPN Research Foundation program produced by Patient Power. We thank Incyte Corporation for their support.

View more programs featuring , and

Produced in association with

Related Programs

MPN News From ASH 2017: Headlines and Updates From an Expert Panel

MPN experts Dr. Mark Heaney, Dr. Rami Komrokji, Dr. Ruben Mesa, Dr. Jamile Shammo and Andrew Schorr discuss the latest news and developments related to research and treatment of MPNs from ASH 2017.


ASH 2017 Daily Wrap: Day One

Patient Power founders Andrew and Esther Schorr are joined by MPN expert Dr. Naveen Pemmaraju, as they discuss research news from the 2017 ASH meeting.


Únete a Nuestra Comunidad Regístrate para Eventos Lee Nuestro Último Post

Page last updated on March 22, 2018